Cancer
Malignant Gastric Neoplasm
CI-CAN-00001130Explore in graph →
Top-level652 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001130Explore in graph →
Clinical trials
2,842 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (232)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01231399 | Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer | completed | Phase 1 / Phase 2 | 6 | City of Hope Medical CenterOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT00376987 | Zinc Supplements in Lowering Cadmium Levels in Smokers | completed | Phase 2 | 61 | Wake Forest University Health SciencesOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00534001 | Bupropion in Helping Adults Stop Smoking | completed | Phase 2 | 95 | Roswell Park Cancer InstituteOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT01152645 | Study of ARQ 197 Monotherapy(ARQ 197-004) | completed | Phase 2 | 31 | Kyowa Kirin Co., Ltd.INDUSTRY | 2 | Mar 15, 2017 | clinicaltrials |
| NCT02890511 | A Study DHP107, a Novel Oral Paclitaxel Formulation, in Patients With Advanced Solid Tumours or Gastric Cancer | completed | Phase 1 / Phase 2 | 28 | Daehwa Pharmaceutical Co., Ltd.INDUSTRY | 1 | Feb 13, 2017 | clinicaltrials |
| NCT01441310 | Laparoscopic Sentinel Node Navigation Surgery for Gastric Cancer(SNNS) | completed | Phase 2 | 101 | Seoul National University Bundang HospitalOTHER | 1 | Jan 9, 2017 | clinicaltrials |
| NCT01441336 | Laparoscopic Gastrectomy for Advanced Gastric Cancer | completed | Phase 2 | 204 | Seoul National University Bundang HospitalOTHER | 1 | Jan 9, 2017 | clinicaltrials |
| NCT01938313 | Early Recovery After Surgery (ERAS) Versus Conventional Protocol After Laparoscopic Gastrectomy(ERAS) | completed | Phase 2 | 100 | Seoul National University Bundang HospitalOTHER | 1 | Jan 5, 2017 | clinicaltrials |
| NCT00054457 | Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction | completed | Phase 2 | 46 | Alliance for Clinical Trials in OncologyOTHER | 1 | Dec 13, 2016 | clinicaltrials |
| NCT00022139 | Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | completed | Phase 2 | 56 | Alliance for Clinical Trials in OncologyOTHER | 1 | Dec 7, 2016 | clinicaltrials |
| NCT00040859 | Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer | completed | Phase 2 | 48 | Alliance for Clinical Trials in OncologyOTHER | 1 | Dec 7, 2016 | clinicaltrials |
| NCT00519324 | Efficacy and Safety of Everolimus (RAD001) in Patients With Advanced Gastric Cancer | completed | Phase 2 | 54 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 18, 2016 | clinicaltrials |
| NCT00436241 | A Study of Xeloda (Capecitabine) as First-Line Chemotherapy in Patients With Advanced or Metastatic Gastric Cancer. | completed | Phase 2 | 45 | Hoffmann-La RocheINDUSTRY | 1 | Nov 2, 2016 | clinicaltrials |
| NCT02903498 | The Maintenance Treatment of UFT in Advanced Gastric Cancer | completed | Phase 2 | 58 | Fudan UniversityOTHER | 0 | Oct 12, 2016 | clinicaltrials |
| NCT00454636 | A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer. | completed | Phase 2 | 158 | Hoffmann-La RocheINDUSTRY | 1 | Sep 29, 2016 | clinicaltrials |
| NCT01624025 | A Comparative Study of Salvage Treatment With Combination of Docetaxel and Epirubicin | completed | Phase 2 | 22 | Yonsei UniversityOTHER | 1 | Aug 17, 2016 | clinicaltrials |
| NCT01590719 | A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastroesophageal Cancer | completed | Phase 2 | 123 | Hoffmann-La RocheINDUSTRY | 6 | Aug 9, 2016 | clinicaltrials |
| NCT01953419 | Phase II Study of Pemetrexed in Advanced or Recurrent Gastric Cancer After Chemotherapy | completed | Phase 2 | 34 | Sun Yat-sen UniversityOTHER | 1 | Jul 28, 2016 | clinicaltrials |
| NCT00003137 | Irinotecan in Treating Patients With Advanced Cancer of the Stomach | completed | Phase 2 | 70 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 14, 2016 | clinicaltrials |
| NCT00004235 | Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach | completed | Phase 2 | 47 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 14, 2016 | clinicaltrials |
| NCT01360086 | Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal Junction | completed | Phase 2 | 65 | Federation Francophone de Cancerologie DigestiveOTHER | 1 | May 30, 2016 | clinicaltrials |
| NCT01130805 | A Study of Pazopanib With CAPEOX in AGC Patients | completed | Phase 2 | 66 | Samsung Medical CenterOTHER | 1 | Apr 15, 2016 | clinicaltrials |
| NCT00849615 | Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction(FLOT3) | completed | Phase 2 | 252 | Krankenhaus NordwestOTHER | 1 | Apr 6, 2016 | clinicaltrials |
| NCT00858338 | Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach Cancer | completed | Phase 2 | 28 | NYU Langone HealthOTHER | 1 | Mar 11, 2016 | clinicaltrials |
| NCT00737438 | Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma | completed | Phase 2 | 22 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 3, 2016 | clinicaltrials |
| NCT00982592 | Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer | completed | Phase 2 | 124 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2016 | clinicaltrials |
| NCT01260701 | Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer | completed | Phase 2 | 75 | National Cancer Institute (NCI)NIH | 2 | Jan 18, 2016 | clinicaltrials |
| NCT01099527 | A Trial of RAD001/Capecitabine in Refractory Gastric Cancer | completed | Phase 1 / Phase 2 | 59 | Samsung Medical CenterOTHER | 1 | Dec 29, 2015 | clinicaltrials |
| NCT00857246 | Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancer | completed | Phase 2 | 30 | NYU Langone HealthOTHER | 1 | Dec 7, 2015 | clinicaltrials |
| NCT00397904 | Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin | completed | Phase 2 | 16 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 25, 2015 | clinicaltrials |
| NCT01152853 | PF-00299804 Monotherapy in Patients With HER-2 Positive Advance Gastric Cancer(PF299804-AGC) | completed | Phase 2 | 28 | Seoul National University HospitalOTHER | 1 | Nov 20, 2015 | clinicaltrials |
| NCT00011960 | Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery | completed | Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 1 | Nov 17, 2015 | clinicaltrials |
| NCT02347956 | The Safety and Feasibility of Reduced Port Robotic Distal Gastrectomy Using Single-site for Surgical Treatment of Early Gastric Cancer | completed | Phase 1 / Phase 2 | 19 | Yonsei UniversityOTHER | 1 | Nov 16, 2015 | clinicaltrials |
| NCT01932580 | Pilot Study of Perioperative Docetaxel, Oxaliplatin, and 5-Fluorouracil (FLOT) in Gastroesophageal Adenocarcinoma | completed | Phase 2 | 10 | McGill UniversityOTHER | 1 | Oct 27, 2015 | clinicaltrials |
| NCT01130337 | A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancer | completed | Phase 2 | 36 | Hoffmann-La RocheINDUSTRY | 1 | Oct 1, 2015 | clinicaltrials |
| NCT02521649 | Dose-ranging Study to Evaluate Antibody Response to G17DT in Patients With Gastric Cancer | completed | Phase 2 | 52 | Cancer Advances Inc.INDUSTRY | 0 | Aug 13, 2015 | clinicaltrials |
| NCT02518529 | Study to Assess Tolerability and Safety and Antibody Response to G17DT in Gastric Cancer Patients | completed | Phase 2 | 41 | Cancer Advances Inc.INDUSTRY | 0 | Aug 10, 2015 | clinicaltrials |
| NCT02450032 | Study to Determine the Antibody Response to 500µg G17DT in Treatment of Patients With Gastric Cancer(GC5) | completed | Phase 2 | 12 | Cancer Advances Inc.INDUSTRY | 1 | May 21, 2015 | clinicaltrials |
| NCT01136031 | Paclitaxel and Irinotecan in Advanced Gastric Cancer(TI-2ndAGC) | completed | Phase 1 / Phase 2 | 42 | Seoul National University HospitalOTHER | 1 | May 20, 2015 | clinicaltrials |
| NCT00477711 | A Study of Cetuximab(Erbitux) With Cisplatin and Capecitabine(Xeloda)as 1st Line Treatment in the Advanced Gastric Cancer(EXTRA) | completed | Phase 2 | 41 | Peking UniversityOTHER | 1 | May 19, 2015 | clinicaltrials |
| NCT00842491 | Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer | completed | Phase 2 | 45 | Peking UniversityOTHER | 1 | May 19, 2015 | clinicaltrials |
| NCT01336062 | Trial of ABI-007 Plus S-1 as Second-line Chemotherapy in Advanced Gastric Cancer Patients | completed | Phase 1 / Phase 2 | 19 | Peking UniversityOTHER | 1 | May 19, 2015 | clinicaltrials |
| NCT00718913 | Postoperative Chemotherapy and Chemo-radiotherapy for Resected Gastric Cancer | completed | Phase 2 | 40 | Hellenic Oncology Research GroupOTHER | 1 | May 18, 2015 | clinicaltrials |
| NCT00130689 | Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer | completed | Phase 2 | 43 | Dana-Farber Cancer InstituteOTHER | 1 | May 14, 2015 | clinicaltrials |
| NCT02442362 | TOF Versus SOX in Metastatic Gastric Cancer | completed | Phase 2 / Phase 3 | 60 | The First People's Hospital of ChangzhouOTHER | 0 | May 13, 2015 | clinicaltrials |
| NCT00084617 | Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma | completed | Phase 2 | 39 | National Cancer Institute (NCI)NIH | 1 | May 1, 2015 | clinicaltrials |
| NCT00673673 | FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer | completed | Phase 2 | 39 | Yale UniversityOTHER | 1 | Feb 4, 2015 | clinicaltrials |
| NCT01874938 | A Study of LY2875358 in Participants With MET Positive, Advanced Gastric Cancer | completed | Phase 2 | 15 | Eli Lilly and CompanyINDUSTRY | 2 | Jan 16, 2015 | clinicaltrials |
| NCT01614522 | A Clinical Trial Evaluating the Effect of ASLAN001 in Patients With Recurrent/Metastatic Gastric Cancer Whose Tumors Are Either HER-2 Amplified or Co-expressing HER-1 and HER-2 | completed | Phase 2 | 24 | ASLAN PharmaceuticalsOTHER | 1 | Jan 14, 2015 | clinicaltrials |
Data updated 23 days agoSource updated May 31, 2017source: clinicaltrials